Topical corticosteroids (Solupred® 20 mg) were prescribed as a mouth
rinse 3 times a day. The patient was subjected to regular follow-ups
(Figures 4A, 4B, 4C, 4D, 4E, 4F) and dose tapering after 6 months when
the erosive lesions and symptoms completely regressed (Figures 5A, 5B,
5C, 5D, 5E).
The patient is followed up with the collaboration of the
gastroenterology and hepatology department.